Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Aust Vet J ; 94(3): 64-6, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26914951

ABSTRACT

In this study, we explored the potential utility of the human-focused FilmArray® Respiratory Panel for the diagnosis of a broad range of influenza viruses of veterinary concern as compared with the standard portfolio of recommended TaqMan®-based diagnostic tests. In addition, we discuss some potential operational advantages associated with the use of such integrated sample extraction, amplification and analysis devices in the context of a future long-term, dual-role strategy for the detection of emergency diseases of both human and veterinary concern.


Subject(s)
Influenza in Birds/diagnosis , Influenza, Human/diagnosis , Orthomyxoviridae Infections/veterinary , Orthomyxoviridae/isolation & purification , Swine Diseases/diagnosis , Animals , Birds , Emergencies/veterinary , Humans , Influenza in Birds/virology , Influenza, Human/virology , Orthomyxoviridae Infections/diagnosis , Orthomyxoviridae Infections/virology , Pilot Projects , Point-of-Care Testing , Polymerase Chain Reaction/methods , Reference Values , Swine , Swine Diseases/virology
2.
J Fish Dis ; 38(8): 739-54, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25130771

ABSTRACT

Molecular (PCR) diagnostic tests for the detection and identification of aquareovirus in general, and Tasmanian Atlantic salmon reovirus (TSRV) specifically, were developed, and their diagnostic sensitivity and specificity were determined and compared with virus isolation in cell culture. Intralaboratory and interlaboratory comparison of PCR (conventional hemi-nested RT-PCR & RT-qPCR) and virus isolation in cell culture using finfish cell lines, CHSE-214 and EPC, was carried out for the detection and identification of TSRV using field samples of farmed Atlantic salmon Salmo salar, L. from various aquaculture sites around Tasmania. The interlaboratory comparison of diagnostic methods was carried out between two laboratories, AAHL-CSIRO and DPIPWE-Tasmania. A total of 144 fish from nine sites (12-33 fish per site) were sampled from two regions of Tasmania (Tamar River estuary in the north and Huon River estuary in the south-east) during late spring to early summer of 2009, and the data were analysed using different statistical approaches. The prevalence of TSRV ranged from 6% to 22% in both regions. All the diagnostic methods (data from both laboratories) had high specificity, while the estimated sensitivity varied between tests with RT-qPCR being the most sensitive (95.2%) method followed by virus isolation and then conventional hemi-nested RT-PCR.


Subject(s)
Aquaculture/methods , Fish Diseases/diagnosis , Polymerase Chain Reaction/veterinary , Reoviridae Infections/veterinary , Reoviridae/physiology , Animals , Cell Line , Fish Diseases/epidemiology , Fish Diseases/virology , Molecular Sequence Data , Prevalence , Reoviridae/genetics , Reoviridae Infections/diagnosis , Reoviridae Infections/epidemiology , Reoviridae Infections/virology , Salmo salar/virology , Sensitivity and Specificity , Tasmania
3.
Prev Vet Med ; 116(1-2): 214-9, 2014 Sep 01.
Article in English | MEDLINE | ID: mdl-25049086

ABSTRACT

Atlantic salmon reovirus (TSRV) has been consistently isolated from Atlantic salmon in Tasmania, since first identification in 1990 under the Tasmanian Salmonid Health Surveillance Program (TSHSP). The distribution and prevalence of TSRV was identified using TSHSP data. A data set of 730 fish submissions tested over a period of 15 years was reviewed and analysed to describe the spatial and temporal variation of TSRV in Tasmanian salmonid aquaculture production units. The virus was present throughout Tasmania with the highest reported prevalence of the virus in the south-east region of Tasmania.


Subject(s)
Fish Diseases/epidemiology , Reoviridae Infections/veterinary , Salmo salar , Animals , Aquaculture , Fish Diseases/virology , Prevalence , Reoviridae/physiology , Reoviridae Infections/epidemiology , Reoviridae Infections/virology , Retrospective Studies , Tasmania/epidemiology
5.
Foot Ankle Surg ; 17(3): 119-23, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21783069

ABSTRACT

This paper describes a minimally invasive percutaneous technique for reduction and fixation of distal fibula fractures using plate osteosynthesis. We believe this technique benefits patients with poor quality soft tissue envelopes. So far a total of 25 patients have undergone percutaneous fixation, 22 females and 3 males. At no stage yet has a minimally invasive procedure been abandoned intra-operatively in favour of conversion to an open procedure. The mean age was 61.6 years (range 25-80 years). The mean time to surgery was 2.00 days (range 0-5) and mean time to discharge was 4.20 days (range 1-9). At a minimum of over 1 year's follow-up all fractures have healed, with no delayed unions or complications so far experienced.


Subject(s)
Fibula/injuries , Fibula/surgery , Fracture Fixation/methods , Fractures, Bone/surgery , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Minimally Invasive Surgical Procedures/methods , Retrospective Studies
6.
Knee ; 17(5): 356-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-19897369

ABSTRACT

Salmonella enterica serotype Choleraesuis is a rare infective pathogen in total knee arthroplasty and accounts for less than 1% of all cases. In the United Kingdom, the most prevalent organisms are Staphylococci, which account for over 50% of cases. We present an interesting case report of an infected revision total knee replacement following foreign travel to a region with an increased prevalence of Salmonella. The patient presented typically with an effused knee and raised inflammatory markers. Tissue samples demonstrated Salmonella choleraesuis as the infective organism. Though this serotype has previously been isolated from an infected total hip prosthesis, we believe this could be the first reported case involving a total knee replacement. Following involvement of our microbiology team and aggressive antibiotic therapy, the patient was successfully treated with two-stage revision surgery and at one-year post-op is making a satisfactory recovery.


Subject(s)
Arthroplasty, Replacement, Knee , Prosthesis Failure , Prosthesis-Related Infections/microbiology , Salmonella Infections/microbiology , Salmonella enterica/isolation & purification , Administration, Oral , Aged , Anti-Bacterial Agents/therapeutic use , Cefotaxime/therapeutic use , Ciprofloxacin/therapeutic use , Humans , Injections, Intravenous , Male , Microbial Sensitivity Tests , Prosthesis-Related Infections/therapy , Reoperation , Salmonella Infections/therapy , Salmonella enterica/classification
7.
J Pharmacol Exp Ther ; 301(2): 753-64, 2002 May.
Article in English | MEDLINE | ID: mdl-11961082

ABSTRACT

(-)-Deprenyl and structurally related propargylamines increase neuronal survival independently of monoamine oxidase B (MAO-B) inhibition, in part by decreasing apoptosis. We found that deprenyl and two other propargylamines, one of which does not inhibit monoamine oxidase B, increased survival in trophically withdrawn 6-day nerve growth factor (NGF)- and 9-day NGF-differentiated PC-12 cells but not in NGF naive or 3-day NGF-differentiated PC-12 cells. Four days of prior NGF exposure were required for the propargylamine-mediated antiapoptosis. Studies using actinomycin D, cycloheximide, and camptothecin revealed that the maintenance of both transcription and translation, particularly between 2 and 6 h after trophic withdrawal, was required for propargylamine-mediated antiapoptosis. Metabolic labeling of newly synthesized proteins for two-dimensional protein gel autoradiography and scintillation counting showed that the propargylamines either increased or reduced the levels of new synthesis or induced de novo synthesis of a number of different proteins, most notably proteins in the mitochondrial and nuclear subfractions. Western blotting for whole cell or subcellular fraction lysates showed that the timing of new protein synthesis changes or subcellular redistribution of apoptosis-related proteins induced by the propargylamines were appropriate to antiapoptosis. The apoptosis-related proteins included superoxide dismutases (SOD1 and SOD2), glutathione peroxidase, c-JUN, and glyceraldehyde-3-phosphate dehydrogenase. Most notable were the prevention of apoptotic decreases in BCL-2 levels and increases in mitochondrial BAX levels. In general, (-)-deprenyl-related propargylamines appear to reduce apoptosis by altering the levels or subcellular localization of proteins that affect mitochondrial membrane permeability, scavenge oxidative radicals, or participate in specific apoptosis signaling pathways.


Subject(s)
Apoptosis/physiology , Nerve Growth Factor/metabolism , Pargyline/analogs & derivatives , Pargyline/pharmacology , Propylamines/pharmacology , Animals , Cell Differentiation/drug effects , Cell Survival/drug effects , Culture Media , Culture Media, Serum-Free , PC12 Cells , Protein Synthesis Inhibitors/pharmacology , Rats
8.
Blood ; 98(12): 3290-300, 2001 Dec 01.
Article in English | MEDLINE | ID: mdl-11719366

ABSTRACT

Monocyte differentiation induced by 1,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) is interrupted during the course of acute promyelocytic leukemia (APL). One form of APL is associated with the translocation t(11;17), which joins the promyelocytic leukemia zinc finger (PLZF) and retinoic acid receptor alpha (RARalpha) genes. Because PLZF is coexpressed in the myeloid lineage with the vitamin D(3) receptor (VDR), the interplay between PLZF and VDR was examined. It was found that PLZF interacts directly with VDR. This occurred at least partly through contacts in the DNA-binding domain of VDR and the broad complex, tram-trak, bric-a-brac/pox virus zinc finger (BTB/POZ) domain of PLZF. Moreover, PLZF altered the mobility of VDR derived from nuclear extracts when bound to its cognate binding site, forming a slowly migrating DNA-protein complex. Overexpression of PLZF in a monocytic cell line abrogated 1,25(OH)(2)D(3) activation from both a minimal VDR responsive reporter and the promoter of p21(WAF1/CIP1), a target gene of VDR. Deletion of the BTB/POZ domain significantly relieved PLZF-mediated repression of 1,25(OH)(2)D(3)-dependent activation. In addition, stable, inducible expression of PLZF in U937 cells inhibited the ability of 1,25(OH)(2)D(3) to induce surface expression of the monocytic marker CD14 and morphologic changes associated with differentiation. These results suggest that PLZF may play an important role in regulating the process by which 1,25(OH)(2)D(3) induces monocytic differentiation in hematopoietic cells.


Subject(s)
Calcitriol/pharmacology , Cell Differentiation/drug effects , DNA-Binding Proteins/pharmacology , Monocytes/drug effects , Receptors, Calcitriol/drug effects , Transcription Factors/pharmacology , Binding Sites , Cell Nucleus/chemistry , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/genetics , DNA/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Gene Expression , Humans , Kruppel-Like Transcription Factors , Lymphoma, Large B-Cell, Diffuse , Promoter Regions, Genetic , Promyelocytic Leukemia Zinc Finger Protein , Receptors, Calcitriol/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Transcription, Genetic/drug effects , Transfection , U937 Cells , Zinc Fingers
10.
Blood ; 96(12): 3939-47, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11090081

ABSTRACT

The AML-1/ETO fusion protein, created by the (8;21) translocation in M2-type acute myelogenous leukemia (AML), is a dominant repressive form of AML-1. This effect is due to the ability of the ETO portion of the protein to recruit co-repressors to promoters of AML-1 target genes. The t(11;17)(q21;q23)-associated acute promyelocytic leukemia creates the promyelocytic leukemia zinc finger PLZFt/RAR alpha fusion protein and, in a similar manner, inhibits RAR alpha target gene expression and myeloid differentiation. PLZF is expressed in hematopoietic progenitors and functions as a growth suppressor by repressing cyclin A2 and other targets. ETO is a corepressor for PLZF and potentiates transcriptional repression by linking PLZF to a histone deacetylase-containing complex. In transiently transfected cells and in a cell line derived from a patient with t(8;21) leukemia, PLZF and AML-1/ETO formed a tight complex. In transient assays, AML-1/ETO blocked transcriptional repression by PLZF, even at substoichiometric levels relative to PLZF. This effect was dependent on the presence of the ETO zinc finger domain, which recruits corepressors, and could not be rescued by overexpression of co-repressors that normally enhance PLZF repression. AML-1/ETO also excluded PLZF from the nuclear matrix and reduced its ability to bind to its cognate DNA-binding site. Finally, ETO interacted with PLZF/RAR alpha and enhanced its ability to repress through the RARE. These data show a link in the transcriptional pathways of M2 and M3 leukemia. (Blood. 2000;96:3939-3947)


Subject(s)
DNA-Binding Proteins/genetics , Leukemia, Promyelocytic, Acute/genetics , Oncogene Proteins, Fusion/pharmacology , Proto-Oncogene Proteins , Transcription Factors/genetics , Transcription Factors/pharmacology , Transcription, Genetic/drug effects , Binding Sites , Cell Line , Core Binding Factor Alpha 2 Subunit , DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/metabolism , DNA-Binding Proteins/pharmacology , Gene Expression Regulation/drug effects , Humans , Kruppel-Like Transcription Factors , Leukemia, Myeloid, Acute/etiology , Leukemia, Myeloid, Acute/genetics , Leukemia, Promyelocytic, Acute/etiology , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Nuclear Matrix/drug effects , Oncogene Proteins, Fusion/genetics , Oncogene Proteins, Fusion/metabolism , Promyelocytic Leukemia Zinc Finger Protein , Protein Binding , RUNX1 Translocation Partner 1 Protein , Repressor Proteins/metabolism , Repressor Proteins/pharmacology , Transcription Factors/antagonists & inhibitors , Transcription Factors/metabolism
11.
Mol Cell Biol ; 20(17): 6550-67, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10938130

ABSTRACT

The promyelocytic leukemia zinc finger (PLZF) protein is a transcription factor disrupted in patients with t(11;17)(q23;q21)-associated acute promyelocytic leukemia. PLZF contains an N-terminal BTB/POZ domain which is required for dimerization, transcriptional repression, formation of high-molecular-weight DNA-protein complexes, nuclear sublocalization, and growth suppression. X-ray crystallographic data show that the PLZF BTB/POZ domain forms an obligate homodimer via an extensive interface. In addition, the dimer possesses several highly conserved features, including a charged pocket, a hydrophobic monomer core, an exposed hydrophobic surface on the floor of the dimer, and two negatively charged surface patches. To determine the role of these structures, mutational analysis of the BTB/POZ domain was performed. We found that point mutations in conserved residues that disrupt the dimer interface or the monomer core result in a misfolded nonfunctional protein. Mutation of key residues from the exposed hydrophobic surface suggests that these are also important for the stability of PLZF complexes. The integrity of the charged-pocket region was crucial for proper folding of the BTB/POZ domain. In addition, the pocket was critical for the ability of the BTB/POZ domain to repress transcription. Alteration of charged-pocket residue arginine 49 to a glutamine (mutant R49Q) yields a domain that can still dimerize but activates rather than represses transcription. In the context of full-length PLZF, a properly folded BTB/POZ domain was required for all PLZF functions. However, PLZF with the single pocket mutation R49Q repressed transcription, while the double mutant D35N/R49Q could not, despite its ability to dimerize. These results indicate that PLZF requires the BTB/POZ domain for dimerization and the charged pocket for transcriptional repression.


Subject(s)
DNA-Binding Proteins/chemistry , Repressor Proteins/chemistry , Transcription Factors/chemistry , Transcription, Genetic , Amino Acid Motifs , Amino Acid Sequence , Arginine/chemistry , Cell Line , Circular Dichroism , DNA, Complementary/metabolism , Dimerization , Escherichia coli/metabolism , Fluorescent Antibody Technique , Genes, Reporter , Glutamine/chemistry , Humans , Kruppel-Like Transcription Factors , Molecular Sequence Data , Mutagenesis, Site-Directed , Plasmids/metabolism , Point Mutation , Promyelocytic Leukemia Zinc Finger Protein , Protein Binding , Protein Structure, Secondary , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Structure-Activity Relationship , Temperature , Trypsin/pharmacology , Two-Hybrid System Techniques
12.
Mol Cell Biol ; 20(6): 2075-86, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10688654

ABSTRACT

The ETO protein was originally identified by its fusion to the AML-1 transcription factor in translocation (8;21) associated with the M2 form of acute myeloid leukemia (AML). The resulting AML-1-ETO fusion is an aberrant transcriptional regulator due to the ability of ETO, which does not bind DNA itself, to recruit the transcriptional corepressors N-CoR, SMRT, and Sin3A and histone deacetylases. The promyelocytic leukemia zinc finger (PLZF) protein is a sequence-specific DNA-binding transcriptional factor fused to retinoic acid receptor alpha in acute promyelocytic leukemia associated with the (11;17)(q23;q21) translocation. PLZF also mediates transcriptional repression through the actions of corepressors and histone deacetylases. We found that ETO is one of the corepressors recruited by PLZF. The PLZF and ETO proteins associate in vivo and in vitro, and ETO can potentiate transcriptional repression by PLZF. The N-terminal portion of ETO forms complexes with PLZF, while the C-terminal region, which was shown to bind to N-CoR and SMRT, is required for the ability of ETO to augment transcriptional repression by PLZF. The second repression domain (RD2) of PLZF, not the POZ/BTB domain, is necessary to bind to ETO. Corepression by ETO was completely abrogated by histone deacetylase inhibitors. This identifies ETO as a cofactor for a sequence-specific transcription factor and indicates that, like other corepressors, it functions through the action of histone deactylase.


Subject(s)
Chromosomes, Human, Pair 21 , Chromosomes, Human, Pair 8 , DNA-Binding Proteins/genetics , Gene Expression Regulation, Neoplastic , Leukemia, Myeloid/genetics , Proto-Oncogene Proteins , Transcription Factors/genetics , Translocation, Genetic , Acute Disease , Animals , COS Cells , Humans , Kruppel-Like Transcription Factors , Promyelocytic Leukemia Zinc Finger Protein , RUNX1 Translocation Partner 1 Protein , Transfection , Zinc Fingers
13.
Mol Pharmacol ; 57(1): 2-12, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10617673

ABSTRACT

Antisense oligonucleotides against the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are able to reduce some forms of apoptosis. In those forms, overall GAPDH levels increase and the enzyme accumulates in the nucleus. The monoamine oxidase B (MAO-B) inhibitor, (-)-deprenyl (DEP), its metabolite (-)-desmethyldeprenyl, and a tricyclic DEP analog, CGP3466, can reduce apoptosis independently of MAO-B inhibition and have been found to bind to GAPDH. We used neuronally differentiated PC12 cells to show that DEP, DES, and CGP3466 reduce apoptosis caused by serum and nerve growth factor withdrawal over the concentration range of 10(-) to 10(-13) M. We provide evidence that the DEP-like compounds bind to GAPDH in the PC12 cells and that they prevent both the apoptotic increases in GAPDH levels and nuclear accumulation of GAPDH. In vitro, the compounds enhanced the conversion of NAD(+) to NADH by GAPDH in the presence of AUUUA-rich RNA and converted GAPDH from its usual tetrameric form to a dimeric form. Using cell lysates, we found a marked increase in rates of NAD(+) to NADH conversion in early apoptosis, which was returned toward control values by the DEP-like compounds. Accordingly, the DEP-like compounds appear to decrease glycolysis by preventing the GAPDH increases in early apoptosis. GAPDH dimer may not have the capacity to contribute to apoptosis in a similar manner to the tetramer, which might account for the antiapoptotic capacity of the compounds. These actions on GAPDH, rather than MAO-B inhibition, may contribute to the improvements in Parkinson's and Huntington's diseases found with DEP treatment.


Subject(s)
Apoptosis , Blood Proteins/physiology , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Nerve Growth Factor/physiology , Amphetamines/pharmacology , Animals , Blood Proteins/deficiency , Dimerization , Glyceraldehyde-3-Phosphate Dehydrogenases/chemistry , Glyceraldehyde-3-Phosphate Dehydrogenases/drug effects , Monoamine Oxidase Inhibitors/pharmacology , Nerve Growth Factor/deficiency , Oxepins/pharmacology , PC12 Cells , Protein Conformation , Rats , Selegiline/pharmacology
14.
Neuroreport ; 10(5): 1149-53, 1999 Apr 06.
Article in English | MEDLINE | ID: mdl-10321500

ABSTRACT

Increased expression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are early, critical events in several forms of apoptosis. In order to investigate the subcellular trafficking of GAPDH in vivo, the localization of a GAPDH-green fluorescent protein (GFP) fusion was studied in PC12, HEK 293 and COS-1 cells. In control cells, fusion protein autofluorescence was largely restricted to the cytoplasm, rather than the nuclear concentration favored by GFP alone. In contrast, as early as 30 min after an insult, nuclear fluorescence increased in all cell lines studied. The fusion protein redistribution paralleled the dynamics of endogenous GAPDH. These data suggest that some nuclear GAPDH observed during apoptosis represents protein previously resident in the cytosol. This construct provides an in vivo monitor for an early change in apoptosis.


Subject(s)
Apoptosis/physiology , Cell Nucleus/metabolism , Indicators and Reagents/metabolism , Luminescent Proteins/metabolism , Recombinant Fusion Proteins/metabolism , Animals , Biological Transport/physiology , COS Cells , Glyceraldehyde-3-Phosphate Dehydrogenases/genetics , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Green Fluorescent Proteins , Humans , Luminescent Proteins/genetics , PC12 Cells , Rats , Subcellular Fractions/metabolism , Time Factors , Tissue Distribution/physiology
15.
Biochem Biophys Res Commun ; 257(2): 440-7, 1999 Apr 13.
Article in English | MEDLINE | ID: mdl-10198232

ABSTRACT

MPP+ inhibits mitochondrial complex I and alpha-ketoglutarate dehydrogenase causing necrosis or apoptosis of catecholaminergic neurons. Low glucose levels or glycolytic blockade has been shown to potentiate MPP+ toxicity. We found that MPP+ caused concentration-dependent apoptosis of neuronally differentiated PC12 cells and that glucose, but not pyruvate, supplementation reduced apoptosis. Oligomycin concentrations sufficient to inhibit ATP synthase blocked the decreased apoptosis afforded by glucose supplementation. Laser-scanning confocal microscope imaging of chloromethyl-tetramethylrosamine methyl ester fluorescence to estimate DeltaPsiM showed that MPP+ and atractyloside reduced DeltaPsiM, while cyclosporin A (CSA) and glucose supplementation reversed decreases in DeltaPsiM caused by MPP+. Oligomycin blocked the effect of glucose supplementation on DeltaPsiM. These findings show that (i) MPP+-induced and atractyloside-induced apoptosis are associated with reduced DeltaPsiM; (ii) CSA maintains DeltaPsiM and reduces MPP+-induced apoptosis; and (iii) glucose supplementation maintains DeltaPsiM, likely by glycolytic ATP-dependent proton pumping at ATP synthase and reduces MPP+-induced apoptosis.


Subject(s)
1-Methyl-4-phenylpyridinium/pharmacology , Apoptosis/drug effects , Glucose/pharmacology , Membrane Potentials/drug effects , Mitochondria/drug effects , Proton-Translocating ATPases/metabolism , 1-Methyl-4-phenylpyridinium/antagonists & inhibitors , Animals , Atractyloside/pharmacology , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cell Survival/drug effects , Cyclosporine/pharmacology , DNA Fragmentation/drug effects , Dose-Response Relationship, Drug , Glucose/antagonists & inhibitors , Glucose/metabolism , Glycolysis/drug effects , Microscopy, Confocal , Mitochondria/enzymology , Mitochondria/physiology , Nerve Growth Factors/pharmacology , Oligomycins/pharmacology , PC12 Cells , Proton-Translocating ATPases/antagonists & inhibitors , Pyruvic Acid/pharmacology , Rats , Time Factors
16.
Biochem J ; 335 ( Pt 3): 691-6, 1998 Nov 01.
Article in English | MEDLINE | ID: mdl-9794812

ABSTRACT

The promyelocytic leukaemia (protein) (PML) localizes to multiprotein complexes known as PML nuclear bodies. We found that glyceraldehyde-3-phosphate dehydrogenase (GAPDH) co-immunoprecipitates with PML and co-localizes with PML in nuclear bodies. RNase treatment disrupts the ability of PML and GAPDH to both co-localize and co-immunoprecipitate, indicating that the association between PML and GAPDH depends on the presence of RNA. Disruption of PML bodies contributes towards reduced apoptosis in acute promyelocytic leukaemia and GAPDH induces apoptotic neuronal death. The GAPDH-PML interaction may be involved in the regulation of apoptosis.


Subject(s)
Cell Nucleus/metabolism , Glyceraldehyde-3-Phosphate Dehydrogenases/metabolism , Neoplasm Proteins/metabolism , Nuclear Proteins/metabolism , RNA/metabolism , Transcription Factors/metabolism , 3T3 Cells , Animals , Cell Line , Electrophoresis, Polyacrylamide Gel , Fibroblasts , Glyceraldehyde-3-Phosphate Dehydrogenases/isolation & purification , Humans , Mice , Neoplasm Proteins/isolation & purification , Promyelocytic Leukemia Protein , Ribonucleases , Transcription Factors/isolation & purification , Tumor Suppressor Proteins
17.
J Virol ; 72(5): 3819-26, 1998 May.
Article in English | MEDLINE | ID: mdl-9557665

ABSTRACT

The promyelocytic leukemia (PML) protein forms nuclear bodies which are relocated to the cytoplasm by the RNA virus lymphocytic choriomeningitis virus (LCMV). The viral Z protein directly binds to PML and can relocate the nuclear bodies. Others have observed that LCMV virions may contain ribosomes; hence, we investigated the effects of infection on the distribution of ribosomal P proteins (P0, P1, and P2) with PML as a reference point. We demonstrate an association of PML bodies with P proteins by indirect immunofluorescence and coimmunoprecipitation experiments, providing the first evidence of nucleic acid-binding proteins associated with PML bodies. We show that unlike PML, the P proteins are not redistributed upon infection. Immunofluorescence and coimmunoprecipitation studies indicate that the viral Z protein binds the nuclear, but not the cytoplasmic, fraction of P0. The nuclear fraction of P0 has been associated with translationally coupled DNA excision repair and with nonspecific endonuclease activity; thus, P0 may be involved in nucleic acid processing activities necessary for LCMV replication. During the infection process, PML, P1, and P2 are downregulated but P0 remains unchanged. Further, P0 is present in virions while PML is not, indicating some selectivity in the assembly of LCMV.


Subject(s)
Lymphocytic choriomeningitis virus/metabolism , Neoplasm Proteins/metabolism , Nuclear Proteins/metabolism , Protozoan Proteins , Ribosomal Proteins/metabolism , Transcription Factors/metabolism , Viral Proteins/metabolism , Zinc Fingers , 3T3 Cells , Animals , Cell Fractionation , Cell Line , Cell Nucleus/metabolism , Cricetinae , Cytoplasm/metabolism , HeLa Cells , Humans , Mice , Promyelocytic Leukemia Protein , Subcellular Fractions , Transfection , Tumor Suppressor Proteins , Viral Proteins/genetics
18.
J Neurosci ; 18(3): 932-47, 1998 Feb 01.
Article in English | MEDLINE | ID: mdl-9437015

ABSTRACT

Studies in non-neural cells have suggested that a fall in mitochondrial membrane potential (DeltaPsiM) is one of the earliest events in apoptosis. It is not known whether neural apoptosis caused by nerve growth factor (NGF) and serum withdrawal involves a decrease in DeltaPsiM. We used epifluorescence and laser confocal microscopy with the mitochondrial potentiometric dyes chloromethyl-tetramethylrosamine methyl ester and 5,5',6, 6'-tetrachloro-1,1',3,3'-tetraethybenzimidazol carbocyanine iodide to estimate DeltaPsiM. PC12 cells were differentiated in media containing serum and NGF for 6 d before withdrawal of trophic support. After washing, the cells were incubated with media containing serum and NGF (M/S+N), media without serum and NGF, or media with the "trophic-like" monoamine oxidase B inhibitor, (-)-deprenyl. Mitochondria in cells without trophic support underwent a progressive shift to lower DeltaPsiM values that was significant by 3 hr after washing. The percentages of cells with nuclear chromatin condensation or nuclear DNA fragmentation were not significantly increased above those for cells in M/S+N until 6 hr after washing. Replacement of cells into M/S+N or treatment with (-)-deprenyl markedly reduced the proportion of mitochondria with decreased DeltaPsiM. Measurements of cytoplasmic peroxyl radical levels with 2',7'-dihydrodichlorofluorescein fluorescence and intramitochondrial Ca2+ with dihydro-rhodamine-2-acetylmethyl ester indicated that cytoplasmic peroxyl radical levels were not increased until after 6 hr, whereas increases in intramitochondrial Ca2+ paralleled the decreases in DeltaPsiM. (-)-Deprenyl appeared to alter the relationship between intramitochondrial Ca2+ levels and DeltaPsiM, possibly through its reported capacity to increase the synthesis of proteins such as BCL-2.


Subject(s)
Apoptosis/physiology , Blood Proteins/pharmacology , Mitochondria/metabolism , Nerve Growth Factors/pharmacology , Neuroprotective Agents/pharmacology , Selegiline/pharmacology , Animals , Apoptosis/drug effects , Calcium/metabolism , Cell Nucleus/drug effects , Cell Nucleus/physiology , Chromatin/physiology , Cytoplasm/metabolism , DNA Fragmentation , Free Radicals/metabolism , Image Processing, Computer-Assisted , Intracellular Membranes/physiology , Membrane Potentials/drug effects , Membrane Potentials/physiology , Microscopy, Fluorescence , Mitochondria/drug effects , PC12 Cells , Peroxides/metabolism , Rats
19.
J Cell Sci ; 109 ( Pt 7): 1765-73, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8832399

ABSTRACT

Gap junction channels permit the direct intercellular transfer of ions and small molecules and allow electrotonic coupling within tissues. Porcine aortic endothelial cells were extensively coupled, as assessed by gap junctional transfer of Lucifer yellow and the fluorescent calcium indicators fluo-3 and furaptra, but were not permeable to rhodamine B isothiocyanate-dextran 10S. The subunit composition of gap junction channels of porcine aortic endothelial cells was characterised using both northern blot analysis and RT-PCR techniques. Messenger RNA encoding connexins 37 and 43, but not 26, 32 or 40, were found in freshly isolated and cultured porcine aortic endothelial cells. Western blots using antipeptide antibodies raised to unique sequences of connexins 37, 40 and 43 showed the presence of connexins 37 and 43, but no connexin 40 was detected. Immunostaining with anticonnexin 43 antibodies showed extensive punctate fluorescent decoration of contacting membranes, whilst antibodies to connexin 37 showed predominantly intracellular staining. Caged InsP3 was found to readily permeate endothelial gap junctions. These results show that primary cultures of porcine aortic endothelial cells express connexin 37 and 43, and provide strong evidence that the second messenger molecule InsP3 can permeate porcine endothelial gap junctions.


Subject(s)
Aorta/ultrastructure , Connexins/metabolism , Endothelium, Vascular/ultrastructure , Gap Junctions/metabolism , Inositol 1,4,5-Trisphosphate/metabolism , Amino Acid Sequence , Animals , Aorta/metabolism , Cells, Cultured , Connexins/genetics , Endothelium, Vascular/metabolism , Gap Junctions/ultrastructure , Ion Channel Gating , Molecular Sequence Data , Patch-Clamp Techniques , RNA, Messenger/analysis , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...